You are here

Field Trip Health Ltd.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
FTRP
Associated Securities: 
Field Trip Health Ltd. Warrants
CSE Index: 
Currency: 

Field Trip is a global leader in the development and delivery of psychedelic therapies. With Field Trip Discovery, the Company’s research division, leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics, Field Trip Health clinics for psychedelic therapies operating and opening within North America and Field Trip Digital, the Company’s technology division, building the digital and technological tools to support psychedelic experiences and consciousness expansion, we help people, from those in treatment to those seeking accelerated personal growth, with a simple, evidence-based way to heal and heighten engagement with the world.

You are here

Field Trip Health Ltd. (FTRP)

SEDAR Information

Company Info

Address
30 Duncan Street, Suite 401
Toronto, ON M5V 2C3
Canada
Phone
1-833-222-0084
Fax
1-855-933-1211
Email
investors@fieldtriphealth.com
Website
https://www.meetfieldtrip.com
Listing date
Tuesday, October 6, 2020
Transfer Agent
Computershare Investor Services Inc.
Auditor
MNP LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
42,166,313
Reserved for Issuance: 
6,441,832

Company Officers

Joseph del Moral, Chief Executive Officer
Donna Wong, Chief Financial Officer
Ronan Levy, Executive Chairman
Hannan Fleiman, President
Mujeeb Jafferi, Chief Operating Officer
Dr. Ryan Yermus, Chief Clinical Officer
Paula Amy Hewitt, General Counsel & Corporate Secretary
Dr. Nathan Bryson, Chief Science Officer
Amardeep Manhas, Chief Technology Officer
Tyler Dyck, Treasurer & Director of Finance

Bulletins

04/01/2021

2021-0101 - New Listing - Field Trip Health Ltd - Warrants (FTRP.WT)

le 4 janvier /January 2021

Field Trip Health Ltd. - Warrants (the "Warrants") have been approved for listing.

The warrants are subject to an accelerated expiry if the volume weighted average trading price of the common shares exceed $9.00 for a period of ten (10) consecutive days. The Issuer will announce by news release and provide written notice to warrant holders of its decision to exercise the acceleration right. Please see the warrant indenture for full details. 

Advertisement

Publicité

Latest CSE News

Upcoming Events